6 Combat HIV/AIDS, malaria and other diseases

Where we are?


The information campaign for youth on healthy life-style and AIDS prevention brought together more than thousand teenagers from different regions of Georgia. June 2009. Photo: David Khizanishvili/UNDP

The number of new HIV infections is steadily increasing even though Georgia remains a low prevalence country.  According to the National AIDS Center, there were 3,080 (2,268 males and 812 females) registered HIV cases as of December 2011. 680 persons died by 2011 as a result of AIDS.

The country is moving towards the eradication of malaria. Currently Georgia is in the phase of prevention of reintroduction of malaria. Introduced  cases of malaria have been reported in 2011 and in 2012. The certification of malaria elimination has been initiated in 2011.

Georgia has made significant progress in confronting epidemic of tuberculosis. According to WHO, estimations the overall TB incidence, mortality and prevalence rates in Georgia have been falling steadily since the year 2000. Despite declines, TB case rates remain relatively high in Georgia.  In 2011, the prevalence of TB (rate per 100,000 population) was 123.4 and incidence (rate per 100,000 population) was 94.2. There is a high burden of multidrug-resistant tuberculosis (MDR-TB) in the country, which greatly complicates Georgia‚Äôs TB epidemic. MDR-TB control was introduced in 2008; universal access to drug resistant TB treatment has been achieved since 2009. TB remains to be particularly severe problem within the penitentiary system.

1.18 years
remaining
until 2015

1990 2015
Targets for MDG6
  1. Halt and begin to reverse the spread of HIV/AIDS
    • HIV prevalence among population aged 15-24 years
    • Condom use at last high-risk sex
    • Proportion of population aged 15-24 years with comprehensive correct knowledge of HIV/AIDS
    • Ratio of school attendance of orphans to school attendance of non-orphans aged 10-14 years
  2. Achieve, by 2010, universal access to treatment for HIV/AIDS for all those who need it
    • Proportion of population with advanced HIV infection with access to antiretroviral drugs